Consumer Genomics Market Report 2025

The consumer genomics market size has grown rapidly in recent years. It will grow from $3.5 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be attributed to sequencing cost reduction, introduction of direct-to-consumer testing, pioneering companies in consumer genomics, data privacy and security concerns, initial adoption challenges.

The consumer genomics market size is expected to see exponential growth in the next few years. It will grow to $8.98 billion in 2029 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to expanded genetic data pool, increasing demand for disease risk assessment, integration with wearable devices, shift toward preventive healthcare, expansion of genetic counseling services. Major trends in the forecast period include focus on genetic counseling services, price reduction in sequencing, rise in personalized medicine, direct-to-consumer testing demand, health and wellness awareness.

The increasing interest in personalized medicine is anticipated to accelerate the expansion of the consumer genomics market in the future. This medical approach customizes treatment and healthcare plans to suit individual patients by considering their distinct genetic, environmental, and lifestyle elements. The surge in the need for personalized medicine is driven by advancements in genetic research, a rise in health awareness, and the quest for more effective therapies with reduced side effects. Consumer genomics plays a vital role in this demand by giving individuals access to their genetic data, enabling them to make knowledgeable health choices and pursue treatments tailored to their genetic traits. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, compared to just six in 2022. Thus, the increasing demand for personalized medicine is fueling the growth of the consumer genomics market.

The growth of the consumer genomics market is anticipated to be driven by the aging population in the coming years. An aging population is characterized by a rising number and proportion of older individuals, typically those aged 60 and above, alongside a declining number and percentage of younger individuals, usually those aged 15 and below. Consumer genomics contributes to understanding healthy aging, catering to the interests of older adults in genealogy testing, and offering insights into disease risks based on personal genetic profiles. For instance, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, projected that the number of Americans aged 65 and older would increase from 58 million in 2022 to 82 million by 2050, representing a 47% growth. Additionally, the share of this age group within the overall population is expected to rise from 17% to 23% during that timeframe. Thus, the aging population is a key factor driving the expansion of the consumer genomics market.

Leading companies in the consumer genomics market are concentrating on technological innovations, particularly analytical solutions, to enhance the interpretation of genomic data, enable quicker and more precise diagnoses, and support personalized medicine efforts. Analytical solutions encompass systematic methods or software tools aimed at processing and analyzing data, allowing organizations to extract valuable insights, recognize trends, and aid in decision-making. For example, in May 2024, SOPHiA GENETICS, a healthcare technology firm based in Switzerland, introduced a new whole genome sequencing (WGS) analytical solution. This cutting-edge technology examines the entire genetic makeup of an organism, providing comprehensive insights into its DNA sequence. The solution combines advanced computational tools, bioinformatics software, and cloud-based platforms to ensure the rapid processing and interpretation of extensive genomic data. By leveraging high-performance computing and artificial intelligence, WGS analytical solutions enable researchers and clinicians to obtain actionable insights quickly, often within a single day. This expedited analysis supports various applications, including personalized medicine and genetic research.

Major players in the consumer genomics market are directing efforts towards the introduction of advanced solutions, such as long-read sequencing systems, to gain a competitive advantage. Long-read sequencing, a form of next-generation sequencing (NGS), offers technical advantages over short-read sequencing for specific types of genetic variation detection. For instance, in October 2022, PacBio, a US-based biotechnology company, launched Revio, a groundbreaking long-read sequencing system. Leveraging advanced NGS technology and cutting-edge NVIDIA GPUs, Revio provides high-throughput, high-quality sequencing data. It is designed for applications in research and clinical settings, including large-scale studies in human genetics, cancer research, agricultural genomics, and more. The system incorporates deep learning algorithms to detect DNA methylation and DeepConsensus, a deep learning technique developed with Google Health to enhance the yield and accuracy of HiFi sequencing, offering accelerated basecalling to meet Revio's higher throughput.

In November 2022, Myriad Genetics, Inc., a US-based genetic testing company, acquired Gateway Genomics, LLC, for $67.5 million. This strategic acquisition enhances access to personalized genetic tests throughout and after a woman's reproductive stage, reinforcing Myriad Genetics' portfolio of women's health products. Gateway Genomics, a US-based personal genomics company and manufacturer of the SneakPeek early gender DNA test, adds valuable offerings to Myriad Genetics' genetic testing capabilities.

Major companies operating in the consumer genomics market include 23andMe Inc., Gene by Gene Ltd., Mapmygenome Ltd., Ancestry.com LLC, Color Genomics Inc., Futura Genetics LLC, Pathway Genomics Corporation, Helix Operating Company LLC, Positive Biosciences Corporation, Veritas Genetics Inc., Amgen Inc., Diagnomics Inc., Toolbox Genomics Inc., Xcode Life Sciences Inc., CircleDNA Inc., DNAfit Ltd., 24Genetics S.L.U., Living DNA Ltd., SelfDecode Inc., MyTrueAncestry Inc., WeGene Technology Co. Ltd., EasyDNA LLC, HomeDNA Inc., Gencove Inc., GenoMind Inc., Genos Inc., Nebula Genomics Corporation, Strategene Corporation.

North America was the largest region in the consumer genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global consumer genomics market report during the forecast period. The regions covered in the consumer genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the consumer genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Consumer genomics is a branch of genomics dedicated to providing genetic information directly to consumers, typically through commercial genetic testing services. These services utilize DNA samples submitted by individuals to generate reports containing information about genetic predispositions to specific traits, diseases, or conditions.

The primary products within the consumer genomics sector include consumables, systems and software, and other related products. In the context of consumer genomics, consumables encompass products and materials utilized in genetic testing, such as collection kits, reagents, and various laboratory supplies. The technologies employed in consumer genomics cover a range of methods, including polymerase chain reaction (PCR), sequencing, microarray, and nucleic acid extraction and purification. Applications of consumer genomics span genetic relatedness, diagnostics, lifestyle insights, ancestry tracing, wellness and nutrition recommendations, reproductive health assessments, personalized medicine and pharmacogenetic testing, sports nutrition and health, and other relevant areas.

The consumer genomics market research report is one of a series of new reports that provides consumer genomics optical components market statistics, including consumer genomics optical components industry global market size, regional shares, competitors with a consumer genomics optical components market share, detailed consumer genomics optical components market segments, market trends and opportunities, and any further data you may need to thrive in the consumer genomics optical components industry. This consumer genomics optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Consumer genomics consists of revenue earned by entities that provide genetic testing services and revenue through various means including Direct-to-consumer (DTC) genetic testing kits, subscription-based services that provide access to ongoing genetic testing and analysis and pharmaceutical or biotechnology companies to provide access to their genetic data for research purposes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.